Asked by: Kwasi Kwarteng (Conservative - Spelthorne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that maternity services are reviewing (a) initiatives and (b) services based on the experiences of bereaved parents to ensure high standards of care for all patients in line with national and local guidelines.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Maternity and Neonatal Voices Partnerships (MNVPs) provide a forum in all areas of England for engagement between maternity services and their users. In November 2023, NHS England published MNVP guidance, which made it clear that effective MNVPs will reach out to seldomly heard groups, including bereaved families. This engagement should be accessible and appropriate.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the 4% increase in NHS dental charges on access to dental care for low-income (a) people and (b) families.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
National Health Service dental charges provide an important contribution to pressurised NHS budgets. It is particularly important to maintain this contribution at sustainable levels, whilst we work to improve NHS dentistry. In setting the charges, we strive to strike a balance between the contribution the charges represent to the overall NHS budget, and the cost to charge-paying patients, recognising the primary policy objectives of improving oral health and guarding against creating financial barriers in accessing NHS dentistry.
We consider that the latest 4% uplift is proportionate, as it remains below the Consumer Prices Index, and represents a £1 increase to a Band 1 course of treatment. To ensure everyone has access to dentistry when needed, there are a range of exemptions to NHS dental patient charges for those who need the most financial support.
The Department has produced an Impact Assessment with respect to the 4% uplift of NHS dental charges for patients in England from April 2024, which is available from the following link:
https://www.legislation.gov.uk/ukia/2024/48/pdfs/ukia_20240048_en.pdf
In line with our Public Sector Equality duty, the Department has also considered the impact of the change on equality, and on those from disadvantaged groups.
Asked by: Kwasi Kwarteng (Conservative - Spelthorne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with NHS England on ensuring that (a) reviews, (b) investigations and (c) complaints processes relating to maternity services include consideration of the (i) impact of ethnicity on the care received and (ii) potential role of (A) racism and (B) discrimination.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England, along with the devolved administrations and the Crown Dependencies, funds Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries to collate ethnicity data, in relation to all perinatal and maternal deaths across the United Kingdom. They publish annual surveillance reports which provide comparators of rates of mortality for women and babies from different ethnic groups. They also publish confidential enquiries, assessing care provision along the whole care pathway, to identify areas requiring improvement.
The Maternity and Newborn Safety Investigations programme provides independent, standardised, and family focused investigations to provide learning to the health system. This includes analysis of data to identify key trends, and collaboration with system partners to escalate safety concerns.
Asked by: Julian Sturdy (Conservative - York Outer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that there are sufficient numbers of Parkinson’s specialist nurses.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Under the NHS Long Term Workforce Plan, backed by more than £2.4 billion over the next five years, the National Health Service will focus on expanding the number of clinicians, including nurses, who train to take up enhanced and advanced roles, and work as part of multidisciplinary teams with the right skills to meet the changing needs of patients. The ambition is to train at least 3,000 advanced practitioners in 2024 and 2025 across all specialties, and to increase the number in training to 5,000 a year by 2029. The Long Term Workforce Plan also sets out actions and reforms needed to improve workforce supply and retention.
Asked by: Julian Sturdy (Conservative - York Outer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that Parkinson’s specialist nurses are retained in the profession.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Under the NHS Long Term Workforce Plan, backed by more than £2.4 billion over the next five years, the National Health Service will focus on expanding the number of clinicians, including nurses, who train to take up enhanced and advanced roles, and work as part of multidisciplinary teams with the right skills to meet the changing needs of patients. The ambition is to train at least 3,000 advanced practitioners in 2024 and 2025 across all specialties, and to increase the number in training to 5,000 a year by 2029. The Long Term Workforce Plan also sets out actions and reforms needed to improve workforce supply and retention.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure (a) transparency and (b) parental consent in clinical trials involving children.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
There are legal measures in place to ensure informed consent in clinical trials, through the Medicines for Human Use (Clinical Trials) Regulations 2004. Parental consent for clinical trials investigating medicines which involve children is also legislated for via the same Regulations.
Promoting and ensuring transparency is central to the role of the Health Research Authority to facilitate safe and ethical research as defined in the Care Act 2014. This includes clinical trials involving children.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what measures are in place to ensure informed consent in clinical trials.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
There are legal measures in place to ensure informed consent in clinical trials, through the Medicines for Human Use (Clinical Trials) Regulations 2004. Parental consent for clinical trials investigating medicines which involve children is also legislated for via the same Regulations.
Promoting and ensuring transparency is central to the role of the Health Research Authority to facilitate safe and ethical research as defined in the Care Act 2014. This includes clinical trials involving children.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she will make an assessment of the potential merits of taking legislative steps to stop private clinics prescribing puberty-blockers to children.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Following the publication of Dr Cass’ Final Report, my Rt hon. Friend, the Secretary of State for Health and Social Care has made a commitment to look closely at what can be done to curtail any loopholes in prescribing practices for children with gender dysphoria, including legislative options.
The Care Quality Commission will expect registered providers to take into account the recommendations of the Cass Review. If a private organisation registered with the Care Quality Commission fails to meet the conditions of its registration, then the regulator can take enforcement action.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2024 to Question 15636 on Blood Cancer: Drugs, on what date her Department first became aware of challenges presented by the appraisal of combination therapies; and what solutions her Department is considering with NHS England to ensure continued equal access to combination medicines for multiple myeloma across the UK.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England, the National Institute for Health and Care Excellence (NICE), and the Association of the British Pharmaceutical Industry (ABPI) worked closely with the Competition and Markets Authority (CMA) over a number of years on the CMA’s statement on combination therapies, published in November 2023.
The steps taken by the CMA provide a clear commercial position that means that deals involving multiple drugs licensed by different companies can now be agreed under specific circumstances. This has been welcomed by the ABPI as an opportunity to unlock the door to more transformative combination therapies on the National Health Service.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the effectiveness of the BALM programme.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England is currently undertaking a review of how health and wellbeing support could be delivered more effectively. As part of this review, the team will: assess NHS England’s current contracts; work with integrated care boards, National Health Service trusts, and primary care organisations to understand the scale and impact of locally provided provision; and work with system partners and stakeholders including royal colleges, the voluntary sector, and the independent sector to understand how demand for these services has changed over recent years.